Market
In the United States, red ginseng extract (Panax ginseng; “red ginseng” preparation) is primarily used as a dietary ingredient in dietary supplements and related wellness products. Because Panax ginseng is native to East Asia, imports are a key supply channel for the extract and its upstream raw material supply chain. U.S. market activity is concentrated in downstream holding, quality release, blending/standardization, contract manufacturing, and consumer retail of finished supplement products. Market access and continuity depend heavily on FDA dietary supplement requirements (DSHEA) and FDA’s import controls for foods, including prior notice submissions for imported articles of food. Quality programs typically emphasize species/plant-part identity and constituent marker testing (e.g., ginsenosides), supported by supplier qualification and traceable lot documentation.
Market RoleImport-dependent consumer market with significant downstream dietary supplement manufacturing
Domestic RoleDownstream formulation, packaging, and retail of dietary supplements containing red ginseng extract
SeasonalityYear-round market availability; extract form reduces seasonal visibility at the U.S. market level.
Risks
Regulatory Compliance HighFDA can detain, refuse, or place imported products on import alert (detention without physical examination) if shipments appear to violate U.S. requirements (e.g., adulteration or misbranding), which can abruptly block or disrupt supply for U.S. importers and brands.Maintain a pre-entry compliance package (product description, labeling/claims review for finished products, supplier controls, and entry readiness) and monitor FDA import alert exposure for relevant product categories and suppliers.
Documentation Gap MediumFailure to submit timely/accurate FDA prior notice for imported articles of food can trigger holds or refusal of admission and add port storage time and rework cost.Implement a shipment checklist tying CBP entry data to FDA prior notice requirements and confirm filings through the chosen submission pathway before arrival.
Food Safety MediumBotanical extract quality risk includes variability in constituent markers (e.g., ginsenosides) and potential contamination or adulteration concerns that can lead to enforcement action, recalls, or retailer delisting in the U.S. market.Use supplier qualification, incoming identity/constituent verification, and risk-based contaminant/adulterant screening aligned to the product’s hazard profile and intended use.
Regulatory Compliance MediumIf the ingredient is considered a “new dietary ingredient” (NDI) for the intended use conditions, lack of an appropriate notification basis can create regulatory exposure for U.S. marketing of the finished supplement.Conduct an NDI status assessment for the specific ingredient form and conditions of use; submit an NDIN when required and retain supporting documentation.
Consumer Safety LowAsian ginseng has documented potential for side effects and interactions with some medications; inadequate consumer-facing risk communication can increase adverse event and complaint risk for finished products sold in the U.S.Ensure label directions and caution statements are appropriate for the intended consumer population and establish compliant adverse event intake and escalation procedures.
Sustainability- Botanical species identity and substitution risk management (Panax ginseng vs. other Panax species) as part of responsible sourcing and quality assurance
- U.S. regulatory scrutiny and conservation controls exist for American ginseng roots (Panax quinquefolius) under CITES Appendix II; while manufactured products such as extracts are treated differently, mixed-species or misdeclared ginseng materials can raise sourcing and documentation concerns
Standards- USP Dietary Supplement Verification Program (USP Verified Mark)
- NSF/ANSI 173 (Dietary Supplements) standard
FAQ
Does the U.S. FDA approve red ginseng extract dietary supplements before they are sold?No. Under the Dietary Supplement Health and Education Act (DSHEA), FDA does not approve dietary supplements for safety and effectiveness before marketing; manufacturers and distributors are responsible for ensuring products are not adulterated or misbranded.
Is FDA prior notice required when importing red ginseng extract into the United States?If the shipment is an article of food being imported or offered for import into the United States, FDA generally requires prior notice to be submitted before arrival so the agency can target import screening and inspections.
When might a New Dietary Ingredient (NDI) notification be relevant for a red ginseng extract used in a U.S. dietary supplement?If the dietary ingredient was not marketed in the United States in a dietary supplement before October 15, 1994, it may be an NDI; in that case, the manufacturer or distributor is responsible for determining status and submitting a notification to FDA at least 75 days before marketing when required.